Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT07168213

Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy

Led by Laval University · Updated on 2026-03-09

30

Participants Needed

1

Research Sites

110 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Several factors can influence oxygenation monitoring and respiratory support through oxygen therapy: the type of oximeter used, skin pigmentation, and the oxygenation target. It is essential to have an accurate measurement of SpO2 in order to optimize the flow of oxygen or FiO2 administered to patients. The question arises as to the impact of these confounding factors on the FiO2 set during high-flow nasal oxygen therapy. The aim of the study is to evaluate the impact of the oxygenation target and the oximeter used on FiO2 in patients receiving high-flow nasal oxygen therapy.

CONDITIONS

Official Title

Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • 18 years of age or older
  • Admitted in intensive care unit
  • Presence of an arterial catheter
  • Receiving high flow nasal oxygen therapy with SpO2 between 88 and 100% and FiO2 between 40 and 80% using the usual oximeter
Not Eligible

You will not qualify if you...

  • No SpO2 signal with the oximeter in use
  • Presence of false nails or nail polish
  • Methemoglobinemia greater than 0.015 on last available arterial blood gas
  • Patient in isolation due to multi-resistant bacteria, C-Difficile, SARS-CoV-2, or similar
  • Expected to require another respiratory support (NIV or mechanical ventilation) within two hours of inclusion

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Institut universitaire de cardiologie et de pneumologie de Québec - Université Laval

Québec, Quebec, Canada, G1V4G5

Actively Recruiting

Loading map...

Research Team

F

Francois Lellouche Principal Investigator

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

CROSSOVER

Primary Purpose

TREATMENT

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Comparison of Two SpO2 Targets With Two Different Oximeters - Impact on FiO2 During Nasal High Flow Oxygen Therapy | DecenTrialz